JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammond, P. B.
Right arrow Articles by Olson, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammond, P. B.
Right arrow Articles by Olson, W. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 157, Issue 1, 196-206, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics

THE MECHANISM OF MOBILIZATION OF LEAD BY ETHYLENEDIAMINETETRAACETATE

P. B. Hammond 1, A. L. Aronson 1, and W. C. Olson 1

1 Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota

The mechanism whereby ethylenediaminetetraacetate (EDTA) acts to increase the excretion of lead was studied. All experiments were conducted on rats which received lead, 7 mg/kg, containing Pb210. The administration of EDTA resulted in marked removal of lead from the bone. This effect was terminated by the end of the period of EDTA infusion. Depletion of the lead burden of soft tissues continued well past the termination of EDTA infusion. Excretion of mobilized lead occurred mainly during the period of EDTA infusion. EDTA had no effect on the ultrafilterability of lead in whole cell suspensions of liver and kidney. The refractoriness of whole cell suspensions to the chelating effect of EDTA was not due to failure of EDTA to penetrate into cells. The efflux of lead from isolated perfused livers was characterized by two first-order rates, one of which was rapid (T1/2 = 0.2-1.1 hr) and the other slow (T1/2 = 34-183 hr). EDTA had no effect on the efflux. Changing the blood in the perfusion reservoir markedly accelerated efflux. Perfusion with nonrecirculating blood or electrolyte solution also generally caused a marked increase in efflux, independent of the presence or absence of EDTA. It is concluded that the effect of EDTA is mainly, if not altogether, on the lead deposited in bone and that the reduction in the lead content of soft tissues is the result of secondary redistribution to the bone.

Submitted on November 7, 1966
Accepted on January 25, 1967




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
S. A. Hamidinia, O. I. Shimelis, B. Tan, W. L. Erdahl, C. J. Chapman, G. D. Renkes, R. W. Taylor, and D. R. Pfeiffer
Monensin Mediates a Rapid and Selective Transport of Pb2+. POSSIBLE APPLICATION OF MONENSIN FOR THE TREATMENT OF Pb2+ INTOXICATION
J. Biol. Chem., October 4, 2002; 277(41): 38111 - 38120.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
M. E. Mortensen and P. D. Walson
Chelation Therapy for Childhood Lead Poisoning: The Changing Scene in the 1990s
Clinical Pediatrics, May 1, 1993; 32(5): 284 - 291.
[PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.